RNA-Binding Proteins Alter Redox Gene Splicing in Biliary Atresia: Insights from Expression Profiling

BACKGROUND: Biliary atresia (BA), the most common cause of extrahepatic obstructive jaundice in infants, is a severe infant disease with a poor prognosis and unclear etiology. RNA-binding proteins (RBPs) are key regulators of alternative splicing and are implicated in various liver pathologies. However, whether RBP dysfunction and resultant aberrant splicing contribute to BA pathogenesis remains unknown. METHODS: We performed an integrated transcriptomic analysis using RNA-seq data from BA patients and normal donor livers (GEO: GSE159720). This encompassed systematic identification of differentially expressed genes (DEGs) and alternative splicing events (ASEs), followed by construction of RBP-ASE coexpression networks to infer underlying regulatory mechanisms. Key bioinformatic predictions were subsequently validated via qRT-PCR in an independent cohort using congenital choledochal cyst (CCC) tissues as controls. RESULTS: Our analysis identified 2022 DEGs and revealed extensive RBP dysregulation, with 135 RBPs showing abnormal expression and 182 exhibiting altered splicing patterns. Notably, 15 RBPs were perturbed at both levels. Coexpression network and functional enrichment analyses demonstrated that RBP-mediated splicing events are significantly involved in metabolic processes, redox homeostasis, and RNA splicing and transport, underscoring their central role in BA pathogenesis. The expression of several RBPs (e.g., FUS, RBM15B) and coexpressed DEGs (e.g., AOX1, ADH6, UGDH) was markedly altered in BA. Similarly, validation of differentially spliced RBPs (e.g., CCNT2, YBX3, TRA2A) and their coexpressed targets (e.g., CFHR2, PRKACB) further corroborated the dysregulation of the RBP-splicing axis. CONCLUSION: In summary, our study links RBP dysregulation and aberrant splicing to biliary atresia, primarily through their association with disrupted redox and metabolic pathways. These findings point to the RBP-splicing axis as a potential contributor to BA pathogenesis and a candidate target for further investigation.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-04-06
DOI
https://doi.org/10.1021/acsomega.6c00317
Primary Topic
Pediatric Hepatobiliary Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RNA-Binding Proteins Alter Redox Gene Splicing in Biliary Atresia: Insights from Expression Profiling

Jiwen Cheng, Ping Cao, Junpeng Hui, Pu Zhao
ACS Omega
Pediatric Hepatobiliary Diseases and Treatments
article

RNA-Binding Proteins Alter Redox Gene Splicing in Biliary Atresia: Insights from Expression Profiling

Jiwen Cheng, Ping Cao, Junpeng Hui, Pu Zhao
article en

Abstract

BACKGROUND: Biliary atresia (BA), the most common cause of extrahepatic obstructive jaundice in infants, is a severe infant disease with a poor prognosis and unclear etiology. RNA-binding proteins (RBPs) are key regulators of alternative splicing and are implicated in various liver pathologies. However, whether RBP dysfunction and resultant aberrant splicing contribute to BA pathogenesis remains unknown. METHODS: We performed an integrated transcriptomic analysis using RNA-seq data from BA patients and normal donor livers (GEO: GSE159720). This encompassed systematic identification of differentially expressed genes (DEGs) and alternative splicing events (ASEs), followed by construction of RBP-ASE coexpression networks to infer underlying regulatory mechanisms. Key bioinformatic predictions were subsequently validated via qRT-PCR in an independent cohort using congenital choledochal cyst (CCC) tissues as controls. RESULTS: Our analysis identified 2022 DEGs and revealed extensive RBP dysregulation, with 135 RBPs showing abnormal expression and 182 exhibiting altered splicing patterns. Notably, 15 RBPs were perturbed at both levels. Coexpression network and functional enrichment analyses demonstrated that RBP-mediated splicing events are significantly involved in metabolic processes, redox homeostasis, and RNA splicing and transport, underscoring their central role in BA pathogenesis. The expression of several RBPs (e.g., FUS, RBM15B) and coexpressed DEGs (e.g., AOX1, ADH6, UGDH) was markedly altered in BA. Similarly, validation of differentially spliced RBPs (e.g., CCNT2, YBX3, TRA2A) and their coexpressed targets (e.g., CFHR2, PRKACB) further corroborated the dysregulation of the RBP-splicing axis. CONCLUSION: In summary, our study links RBP dysregulation and aberrant splicing to biliary atresia, primarily through their association with disrupted redox and metabolic pathways. These findings point to the RBP-splicing axis as a potential contributor to BA pathogenesis and a candidate target for further investigation.

ACS OmegaVol. 11(15)
First Affiliated Hospital of Xi'an Jiaotong University (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Xi’an Children’s Hospital (CN)
National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province
No poverty
Openalex Percentile: Top 33%
Pediatric Hepatobiliary Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.